Skip to main content
43°
Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Protalix Biotherapeutics
(NY:
PLX
)
1.150
UNCHANGED
Streaming Delayed Price
Updated: 8:00 PM EDT, Apr 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.150
Bid (Size)
1.130 (119)
Ask (Size)
1.200 (29)
Prev. Close
1.150
Today's Range
1.150 - 1.150
52wk Range
1.130 - 3.550
Shares Outstanding
73,052,124
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Earnings Scheduled For March 14, 2024
March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
Via
Benzinga
Earnings Preview: Protalix BioTherapeutics
March 13, 2024
Via
Benzinga
Performance
YTD
-36.81%
-36.81%
1 Month
-9.45%
-9.45%
3 Month
-25.32%
-25.32%
6 Month
-19.58%
-19.58%
1 Year
-52.87%
-52.87%
More News
Read More
Earnings Scheduled For November 6, 2023
November 06, 2023
Via
Benzinga
Earnings Preview For Protalix BioTherapeutics
November 03, 2023
Via
Benzinga
Preview: Protalix BioTherapeutics's Earnings
August 04, 2023
Via
Benzinga
Pullix Gains Momentum As Gamestop Exits NFT Space
January 14, 2024
Via
Talk Markets
Protalix BioTherapeutics And 2 Other Penny Stocks Insiders Are Buying
October 23, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 07, 2023
Via
Benzinga
Fabry Disease Treatment Showdown: Protalix Bio's Elfabrio Joins the Ranks of Sanofi and Amicus Therapeutics
May 10, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 10, 2023
Via
InvestorPlace
Protalix Clocks 40% Decline In Q1 Revenues Reflecting Lower Sales To Brazil
May 04, 2023
Via
Benzinga
Earnings Preview For Protalix BioTherapeutics
February 24, 2023
Via
Benzinga
Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket
February 27, 2023
Via
Benzinga
$12.5 Million Bet On Biodesix? Check Out These 4 Penny Stocks Insiders Are Buying
January 06, 2023
Via
Benzinga
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 30, 2022
Via
News Direct
Exposures
Product Safety
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 30, 2022
Via
TheNewswire.com
Exposures
Product Safety
Earnings Scheduled For February 27, 2023
February 27, 2023
Via
Benzinga
Looking Into Protalix BioTherapeutics's Return On Capital Employed
December 23, 2022
Via
Benzinga
Protalix BioTherapeutics Well Placed to Advance in 2023
December 12, 2022
Via
Talk Markets
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 29, 2022
Via
Benzinga
Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform Investment Decisions
September 21, 2022
Via
TheNewswire.com
Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform Investment Decisions
September 21, 2022
Via
News Direct
Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform Investment Decisions
September 20, 2022
Via
Benzinga
Earnings Scheduled For November 14, 2022
November 14, 2022
Via
Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.